Precision BioSciences is a clinical-stage biotechnology company focused on gene editing therapies. The company actively advances its proprietary ARCUS platform to develop in vivo gene editing treatments for complex diseases. This strategic focus drives the implementation of specialized systems across research, manufacturing, and clinical operations to support its drug development pipeline.
This deep reliance on advanced scientific platforms and global clinical trials creates significant system dependencies and operational challenges. Managing complex genomic data, ensuring regulatory compliance across multiple jurisdictions, and scaling specialized manufacturing processes introduce specific risks and potential breakdowns. This page analyzes Precision BioSciences’s key digital transformation initiatives, identifies associated challenges, and outlines potential sales opportunities.
Precision BioSciences Snapshot
Headquarters: Durham, United States
Number of employees: 192 (2022)
Public or private: Public
Business model: B2B
Website: http://www.precisionbiosciences.com
Precision BioSciences ICP and Buying Roles
Precision BioSciences sells to pharmaceutical companies and research institutions needing advanced gene editing technologies. They also collaborate with organizations focused on developing specific disease therapies.
Who drives buying decisions
- Chief Medical Officer → Clinical trial strategy and patient safety protocols
- Head of Research and Development → Scientific platform evaluation and pipeline advancement
- VP of Regulatory Affairs → Compliance with global health authority requirements
- Head of Business Development → Strategic partnerships and licensing agreements
Key Digital Transformation Initiatives at Precision BioSciences (At a Glance)
- Expanding global Clinical Trial Management Systems.
- Implementing Manufacturing Process Data Management Systems.
- Developing Bioinformatics Data Pipelines and Analytics Platforms.
- Automating Regulatory Affairs Document Management.
Where Precision BioSciences’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Clinical Trial Management Systems | Expanding global Clinical Trial Management Systems: patient enrollment tracking delays trial timelines. | Head of Clinical Operations, Clinical Project Manager, VP of R&D | Centralize patient data capture and site activation workflows. |
| Expanding global Clinical Trial Management Systems: data discrepancies occur from manual site entry. | Clinical Data Manager, Regulatory Affairs Lead | Validate clinical data upon entry to maintain data integrity. | |
| Expanding global Clinical Trial Management Systems: regulatory submission processes for new sites break. | Regulatory Affairs Director, Clinical Operations Manager | Route regulatory documents for approval before submission. | |
| Process Data Management Platforms | Implementing Manufacturing Process Data Management Systems: manual batch record transcription creates data issues. | Head of Manufacturing, Quality Assurance Director, Process Development Lead | Standardize batch data capture directly from equipment. |
| Implementing Manufacturing Process Data Management Systems: quality assurance reviews stall with paper-based documentation. | Quality Control Manager, Plant Manager | Enforce digital audit trails for all manufacturing process changes. | |
| Implementing Manufacturing Process Data Management Systems: production bottlenecks arise from lack of real-time process visibility. | Head of Operations, Production Supervisor | Detect deviations in process parameters instantly. | |
| Bioinformatics and Data Platforms | Developing Bioinformatics Data Pipelines: disparate data formats block data integration. | Head of Bioinformatics, Data Engineering Lead, Research Scientist | Standardize data ingestion from diverse scientific instruments. |
| Developing Bioinformatics Data Pipelines: quality control checks on raw genomic data require extensive manual review. | Computational Biologist, Biostatistician | Detect anomalies in genomic sequencing data automatically. | |
| Developing Bioinformatics Data Pipelines: scientific teams cannot access consolidated analysis data. | VP of Data Science, Translational Medicine Lead | Validate data readiness for downstream analysis and reporting. | |
| Regulatory Information Management Systems | Automating Regulatory Affairs Document Management: manual dossier compilation causes version control issues. | Regulatory Affairs Manager, Document Control Specialist | Prevent unauthorized document modifications in submission dossiers. |
| Automating Regulatory Affairs Document Management: submission deadlines are missed due to inefficient approval workflows. | VP of Regulatory Affairs, Compliance Officer | Route documents for review and approval across departments. | |
| Automating Regulatory Affairs Document Management: audit trails for document changes are difficult to maintain. | Quality Assurance Lead, Legal Counsel | Enforce a complete historical record for every regulatory submission document. |
Identify when companies like Precision BioSciences are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Precision BioSciences’s digital transformation unique
Precision BioSciences’s digital transformation focuses heavily on integrating its proprietary ARCUS gene editing platform across all operational stages. This demands systems capable of managing highly complex genomic data while adhering to stringent pharmaceutical regulatory requirements. Their approach prioritizes precision and control over the gene editing process from discovery through clinical trials, making data integrity and automated compliance exceptionally critical. This creates a unique need for specialized biotech-specific system integrations beyond typical enterprise solutions.
Precision BioSciences’s Digital Transformation: Operational Breakdown
DT Initiative 1: Expanding global Clinical Trial Management Systems
What the company is doing
Precision BioSciences deploys advanced Clinical Trial Management Systems to manage its multi-country studies for gene editing therapies. This centralizes the oversight of patient recruitment, data collection, and site performance. The company actively enrolls patients across diverse global locations, including the US, UK, France, Romania, Moldova, New Zealand, and Hong Kong.
Who owns this
- Head of Clinical Operations
- Clinical Project Manager
- VP of R&D
- Regulatory Affairs Lead
Where It Fails
- Patient enrollment tracking across global sites causes delays in trial timelines.
- Data entry from external clinical sites introduces data discrepancies.
- Regulatory document submissions for new trial sites are inconsistent.
- Centralized monitoring tools do not flag protocol deviations from remote sites.
Talk track
Noticed Precision BioSciences expands its global clinical trial network for therapies like PBGENE-HBV. Been looking at how some biotech companies are validating patient enrollment data automatically instead of manual reconciliation, can share what’s working if useful.
DT Initiative 2: Implementing Manufacturing Process Data Management Systems
What the company is doing
Precision BioSciences implements process data management software in its cGMP manufacturing facilities. This initiative aims to digitize batch data recording, standardize process parameters, and provide real-time visibility into gene therapy production. The system captures data directly from manufacturing equipment.
Who owns this
- Head of Manufacturing
- Quality Assurance Director
- Process Development Lead
- Plant Manager
Where It Fails
- Manual transcription of batch records introduces data discrepancies in the Manufacturing Execution System.
- Quality assurance reviews stall due to paper-based documentation requiring physical sign-offs.
- Production bottlenecks arise from lack of real-time visibility into process deviations.
- Equipment calibration logs are inconsistent between manual and digital records.
Talk track
Saw Precision BioSciences uses process data management for manufacturing operations. Been looking at how some biopharma teams are standardizing batch data capture at the source instead of manual transcription, happy to share what we’re seeing.
DT Initiative 3: Developing Bioinformatics Data Pipelines and Analytics Platforms
What the company is doing
Precision BioSciences builds and maintains advanced data pipelines for processing and analyzing complex genomic and biomarker data. This includes data from preclinical research, clinical studies, and gene editing experiments. The company focuses on consolidating diverse datasets for scientific discovery.
Who owns this
- Head of Bioinformatics
- Data Engineering Lead
- Research Scientist
- Computational Biologist
Where It Fails
- Disparate data formats from research instruments block efficient data integration into centralized platforms.
- Quality control checks on raw genomic data require extensive manual review by scientific teams.
- Scientific teams struggle to access consolidated data for advanced computational analysis.
- Biomarker data validation fails before ingestion into downstream analytics platforms.
Talk track
Looks like Precision BioSciences develops bioinformatics data pipelines for gene editing. Been seeing teams standardize data ingestion from diverse lab instruments instead of manual data preparation, can share what’s working if useful.
DT Initiative 4: Automating Regulatory Affairs Document Management
What the company is doing
Precision BioSciences automates the assembly, submission, and lifecycle management of regulatory documents for drug development. This streamlines the process for Clinical Trial Applications (CTAs) and Investigational New Drug (IND) applications across various health authorities. The system manages version control and approval workflows for all regulatory submissions.
Who owns this
- VP of Regulatory Affairs
- Regulatory Affairs Manager
- Document Control Manager
- Quality Assurance Lead
Where It Fails
- Manual compilation of regulatory dossiers causes version control issues across global teams.
- Submission deadlines are missed due to inefficient document approval workflows.
- Audit trails for document changes become incomplete or difficult to maintain for inspectors.
- Compliance checks on submitted documents fail before final health authority review.
Talk track
Seems like Precision BioSciences manages many regulatory submissions for clinical trials. Been seeing teams enforce document version control automatically instead of relying on manual checks, happy to share what we’re seeing.
Who Should Target Precision BioSciences Right Now
This account is relevant for:
- Clinical Data Management System providers
- Manufacturing Execution Systems (MES) for biotech
- Bioinformatics and Genomic Data Platform vendors
- Regulatory Information Management (RIM) system providers
- Quality Management System (QMS) for GxP environments
- Specialized AI/ML platforms for drug discovery data
Not a fit for:
- Generic HR and payroll software
- Basic marketing automation platforms
- Standard CRM systems without life sciences specialization
- General IT infrastructure vendors lacking GxP compliance expertise
When Precision BioSciences Is Worth Prioritizing
Prioritize if:
- You sell solutions that centralize patient enrollment and site activation across global clinical trials.
- You sell systems that standardize batch data capture directly from biotech manufacturing equipment.
- You sell platforms that integrate diverse genomic data formats for bioinformatics analysis.
- You sell tools that automate regulatory document version control and approval workflows.
- You sell Quality Management Systems that enforce GxP compliance for manufacturing processes.
Deprioritize if:
- Your solution does not address any of the breakdowns above.
- Your product is limited to basic functionality without specialized biotech integrations.
- Your offering lacks specific features for GxP validation or regulatory compliance.
Who Can Sell to Precision BioSciences Right Now
Clinical Trial Management Systems
Veeva Systems - This company provides cloud-based software for the life sciences industry, including clinical data management and regulatory solutions.
Why they are relevant: Precision BioSciences faces delays in clinical trial timelines due to fragmented patient data and inconsistent site management. Veeva Systems can centralize clinical data operations, automate site activation processes, and enforce data consistency across all global trial locations, preventing operational roadblocks.
Medidata Solutions - This company offers a unified platform for clinical research, including Electronic Data Capture (EDC) and Clinical Trial Management (CTM) solutions.
Why they are relevant: Data discrepancies occur from manual data entry at Precision BioSciences' clinical sites, impacting data quality and regulatory compliance. Medidata Solutions can provide standardized, real-time data capture tools, validate incoming clinical data, and reduce errors before data propagates to central repositories.
Manufacturing Process Data Management Platforms
Skyland Analytics - This company provides a Process Information Management System (PIMS) for biopharmaceutical manufacturing data lifecycle management.
Why they are relevant: Manual batch record transcription at Precision BioSciences' cGMP facility introduces critical data discrepancies and slows quality assurance processes. Skyland PIMS can directly integrate with manufacturing equipment, standardize batch data collection, and provide an auditable digital record for all production steps, ensuring data integrity.
AspenTech - This company offers asset optimization software for process industries, including manufacturing execution systems and process simulation.
Why they are relevant: Precision BioSciences experiences production bottlenecks from a lack of real-time visibility into manufacturing process performance. AspenTech's MES solutions can detect deviations in critical process parameters instantly, provide real-time operational insights, and prevent issues before they impact batch quality or production schedules.
Bioinformatics and Genomic Data Platforms
DNAnexus - This company provides a cloud-based platform for genomic and multi-omic data analysis and collaboration.
Why they are relevant: Precision BioSciences struggles with disparate data formats from research instruments, blocking efficient integration into analytics platforms. DNAnexus can standardize data ingestion from diverse genomic sequencers and lab instruments, centralize storage, and prepare data for downstream bioinformatics pipelines.
Seven Bridges Genomics - This company offers a bioinformatics platform for analyzing and managing large-scale genomic data.
Why they are relevant: Quality control checks on raw genomic data at Precision BioSciences require extensive manual review by scientific teams, slowing discovery. Seven Bridges Genomics can automate quality control processes, detect anomalies in sequencing data, and validate data integrity before it enters the analysis workflow.
Regulatory Information Management (RIM) Systems
IQVIA Technologies (formerly R&D Solutions) - This company offers a suite of technology solutions for regulatory affairs and clinical development.
Why they are relevant: Precision BioSciences experiences version control issues and missed deadlines due to manual compilation and approval of regulatory dossiers. IQVIA's RIM solutions can prevent unauthorized changes to regulatory documents, automate document routing for review and approval, and maintain comprehensive audit trails for all submissions.
EXTEDO - This company provides software solutions for regulatory information management, electronic submissions, and pharmacovigilance.
Why they are relevant: Inefficient document approval workflows at Precision BioSciences delay regulatory submissions and compliance efforts. EXTEDO can enforce structured approval workflows, track document status in real-time, and ensure all necessary sign-offs occur before packaging submissions for health authorities, preventing delays.
Final Take
Precision BioSciences scales its gene editing platform and global clinical trial operations, creating complex data and regulatory challenges. Breakdowns occur in clinical data management, manufacturing process data integrity, bioinformatics pipeline efficiency, and regulatory document control. This account is a strong fit for vendors providing specialized solutions that standardize data, automate compliance, and orchestrate critical workflows within the highly regulated biotechnology space.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.